Analyst Ratings for Spruce Biosciences, Inc. (SPRB)
SPRB Rating Summary
SPRB Price Target Summary
- Highest: $283.00 (Oppenheimer)
- Lowest: $160.00 (Leerink Partners)
- Average: $205.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$205.75 (+268.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 64%
Avg. $ Target:
$205.75 (+268.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/23/2025 | Oppenheimer | Leland Gershell | New Coverage | Outperform (N/A) |
283.00 (N/A) |
82.82 (55.87) |
-32.54% | Details |
| 12/22/2025 | H.C. Wainwright » Updated 2/19/2026 |
Raghuram Selvaraju | New Coverage | Buy (Buy) |
200.00 (220.00) |
78.74 (55.87) |
-29.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
